
Clinical use of non-steroidal anti-inflammatory drugs (NSAIDs) carries cardiovascular risk, which acquires implications for public health against the backdrop of rising chronic disease rates in low- and middle-income countries (LMICs). New evidence from an international study conducted by Patricia McGettigan and David Henry and published this week in PLOS Medicine [1] sheds light on how emerging evidence about NSAID risk is poorly translated into practice and sales in countries around the world, raising questions about the use and promotion of potentially harmful drugs…
Read more »
Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk
Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used of therapeutic agents. Taken singly or in combination with other classes of drug, they relieve symptoms across multiple clinical indications, including short and long term pain states and a range of musculoskeletal disorders.
Read more »